(Q43914636)

English

Development and validation of a risk scoring tool to predict respiratory syncytial virus hospitalization in premature infants born at 33 through 35 completed weeks of gestation

scientific article published on 12 June 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

28 November 2017

Development and validation of a risk scoring tool to predict respiratory syncytial virus hospitalization in premature infants born at 33 through 35 completed weeks of gestation (English)

1 reference

Europe PubMed Central

28 November 2017

0 references

hospitalization

1 reference

based on heuristic

inferred from title

Joanne M. Langley

2

1 reference

Europe PubMed Central

28 November 2017

Xavier Carbonell-Estrany

3

object named as

Xavier Carbonell-Estrany

1 reference

Europe PubMed Central

28 November 2017

author name string

John S Sampalis

1

1 reference

Europe PubMed Central

28 November 2017

Bosco Paes

4

1 reference

Europe PubMed Central

28 November 2017

Karel O'Brien

5

1 reference

Europe PubMed Central

28 November 2017

Upton Allen

6

1 reference

Europe PubMed Central

28 November 2017

Ian Mitchell

7

1 reference

Europe PubMed Central

28 November 2017

José Figueras Aloy

8

1 reference

Europe PubMed Central

28 November 2017

Carmen Pedraz

9

1 reference

Europe PubMed Central

28 November 2017

Andrea F Michaliszyn

10

1 reference

Europe PubMed Central

28 November 2017

publication date

12 June 2008

1 reference

Europe PubMed Central

28 November 2017

Medical Decision Making

1 reference

Europe PubMed Central

28 November 2017

28

1 reference

Europe PubMed Central

28 November 2017

471-480

1 reference

Europe PubMed Central

28 November 2017

4

1 reference

Europe PubMed Central

28 November 2017

Increasing incidence of hospitalization for bronchiolitis among Canadian children, 1980-2000.

1 reference

https://api.crossref.org/works/10.1177%2F0272989X08315238

21 January 2018

Bronchiolitis-associated hospitalizations among US children, 1980-1996.

1 reference

https://api.crossref.org/works/10.1177%2F0272989X08315238

21 January 2018

Review of epidemiology and clinical risk factors for severe respiratory syncytial virus (RSV) infection

1 reference

https://api.crossref.org/works/10.1177%2F0272989X08315238

21 January 2018

Rates of hospitalization for respiratory syncytial virus infection among children in medicaid

1 reference

https://api.crossref.org/works/10.1177%2F0272989X08315238

21 January 2018

Identifying risk factors for severe respiratory syncytial virus among infants born after 33 through 35 completed weeks of gestation: different methodologies yield consistent findings

1 reference

https://api.crossref.org/works/10.1177%2F0272989X08315238

21 January 2018

Risk factors for respiratory syncytial virus-associated lower respiratory illnesses in the first year of life

1 reference

https://api.crossref.org/works/10.1177%2F0272989X08315238

21 January 2018

Rehospitalization for respiratory syncytial virus among premature infants.

1 reference

https://api.crossref.org/works/10.1177%2F0272989X08315238

21 January 2018

Hospital admission of high risk infants for respiratory syncytial virus infection: implications for palivizumab prophylaxis

1 reference

https://api.crossref.org/works/10.1177%2F0272989X08315238

21 January 2018

The Pediatric Investigators Collaborative Network on Infections in Canada study of predictors of hospitalization for respiratory syncytial virus infection for infants born at 33 through 35 completed weeks of gestation

1 reference

https://api.crossref.org/works/10.1177%2F0272989X08315238

21 January 2018

Effect of prematurity on respiratory syncytial virus hospital resource use and outcomes

1 reference

https://api.crossref.org/works/10.1177%2F0272989X08315238

21 January 2018

Complications in infants hospitalized for bronchiolitis or respiratory syncytial virus pneumonia

1 reference

https://api.crossref.org/works/10.1177%2F0272989X08315238

21 January 2018

Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections

1 reference

https://api.crossref.org/works/10.1177%2F0272989X08315238

21 January 2018

Prevention of respiratory syncytial virus infections in high-risk infants by monoclonal antibody (palivizumab).

1 reference

https://api.crossref.org/works/10.1177%2F0272989X08315238

21 January 2018

Case-control study of the risk factors linked to respiratory syncytial virus infection requiring hospitalization in premature infants born at a gestational age of 33-35 weeks in Spain

1 reference

https://api.crossref.org/works/10.1177%2F0272989X08315238

21 January 2018

A new and improved population-based Canadian reference for birth weight for gestational age.

1 reference

https://api.crossref.org/works/10.1177%2F0272989X08315238

21 January 2018

Recent trends in severe respiratory syncytial virus (RSV) among US infants, 1997 to 2000

1 reference

https://api.crossref.org/works/10.1177%2F0272989X08315238

21 January 2018

Risk factors for hospitalization due to respiratory syncytial virus infection among infants in the Basque Country, Spain.

1 reference

https://api.crossref.org/works/10.1177%2F0272989X08315238

21 January 2018

Hospitalization for respiratory syncytial virus infection in young children: development of a clinical prediction rule

1 reference

https://api.crossref.org/works/10.1177%2F0272989X08315238

21 January 2018

Clinical characteristics of respiratory syncytial virus infections in healthy versus previously compromised host

1 reference

https://api.crossref.org/works/10.1177%2F0272989X08315238

21 January 2018

Risk of severe respiratory syncytial virus disease, identification of high risk infants and recommendations for prophylaxis with palivizumab

1 reference

https://api.crossref.org/works/10.1177%2F0272989X08315238

21 January 2018

Hospitalization Attributable to Influenza and Other Viral Respiratory Illnesses in Canadian Children

1 reference

https://api.crossref.org/works/10.1177%2F0272989X08315238

21 January 2018

Identifiers

10.1177/0272989X08315238

1 reference

Europe PubMed Central

28 November 2017

1 reference

Europe PubMed Central

28 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43914636&oldid=2104362451"